Stockscreener 앱 받기
0.3501
14.08%
-0.0589
전일 마감가:
$0.409
열려 있는:
$0.36
하루 거래량:
1.23M
Relative Volume:
0.23
시가총액:
$2.32M
수익:
-
순이익/손실:
$-16.89M
주가수익비율:
-0.0168
EPS:
-20.8847
순현금흐름:
$-16.44M
1주 성능:
-33.59%
1개월 성능:
-4.64%
6개월 성능:
-91.01%
1년 성능:
-95.59%
1일 변동 폭
$0.34
$0.375
1주일 범위
$0.34
$0.6339
52주 변동 폭
$0.2907
$14.14
Glucotrack Inc Stock (GCTK) Company Profile
명칭
Glucotrack Inc
전화
972 (8) 675-7878
주소
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.3534 | 2.68M | 0 | -16.89M | -16.44M | -20.88 |
ISRG
Intuitive Surgical Inc
|
357.32 | 125.08B | 11.03B | 3.16B | 2.83B | 8.7254 |
BDX
Becton Dickinson Co
|
153.95 | 42.57B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.62 | 32.88B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.94 | 34.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
196.22 | 28.81B | 5.54B | 1.52B | 1.74B | 10.37 |
Glucotrack Inc 주식(GCTK)의 최신 뉴스
GlucoTrack (GCTK) stock rallies 16% after hours: Here's what is going on - MSN
Press Release: Glucotrack, Inc. and Lōkahi Therapeutics(TM) Announce Strategic Financing Support From E.F. Hutton & Co. in Connection With Their Recently Completed Business Combination and Future Capital Markets Initiatives - Moomoo
Glucotrack completes bridge financing after merger By Investing.com - Investing.com South Africa
Glucotrack, Inc. (NASDAQ: GCTK) sets 2026 vote on reverse split and warrants - Stock Titan
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing - The Manila Times
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on - GlobeNewswire
Glucotrack Gains Slightly on Bridge Financing Deal - Baystreet.ca
Glucotrack Secures Bridge Financing Following Lōkahi Merger to Support Growth and Future Capital Raises - citybiz
Glucotrack completes bridge financing after merger - Investing.com
Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives - The Manila Times
Lōkahi students assess shelved clinical assets for new opportunities - Stock Titan
GlucoTrack (GCTK) Stock Rallies 16% After Hours: Here's What Is Going On - Benzinga
Glucotrack completes business combination with Lōkahi Therapeutics - Investing.com
GlucoTrack and Lokahi Therapeutics: Paul Goode Will Serve as Chief Technical Officer of Combined Co and CEO of CBGM Subsidiary - Moomoo
GlucoTrack and Lokahi Therapeutics: Erik Emerson Appointed CEO of Combined Co - Moomoo
UPDATEGlucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform - The Manila Times
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Glucotrack Completes Strategic Business Combination with Lōkahi Therapeutics to Form Publicly Listed Healthcare Platform - Quiver Quantitative
Press Release: UPDATE -- Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform - Moomoo
Glucotrack and Lōkahi Therapeutics Merge to Form Capital-Efficient Public Biopharma Platform Leveraging AI-Driven Asset Development 12 – Minichart - Minichart
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), upon the completion of the merger transaction between GlucoTrack, Inc. and Lokahi, the existing shareholders of Lokahi will receive shares equivalent to 19.99% of - Bitget
The board of Sprout Social, Inc. officially approved a personnel streamlining plan on July 8, 2026. - Bitget
Glucotrack appoints Erik Emerson to Acquiror board following expansion - TradingView
Glucotrack, Inc. (NASDAQ: GCTK) shifts control to Lokahi, adds $50M equity line - Stock Titan
Glucotrack Completes Lōkahi Therapeutics Business Combination, Creating AI-Driven Healthcare Platform - Yahoo Finance
Glucotrack Combines with Lōkahi Therapeutics - Medical Product Outsourcing
Glucotrack (GCTK) Stock Is Trending Overnight — Here’s Why it Spiked Over 69% in After-Hours Session - Benzinga
Glucotrack and Lōkahi Therapeutics Complete Strategic - GlobeNewswire
Glucotrack, Inc. and Lokahi Therapeutics Announces Executive Appointments to Its Combined Company - marketscreener.com
Glucotrack receives patent allowance for glucose monitoring system By Investing.com - Investing.com Nigeria
Lokahi Therapeutics Inc. entered into an Agreement and Plan of Merger to acquire GlucoTrack, Inc. in a reverse merger transaction. - marketscreener.com
GlucoTrack Inc (NASDAQ: GCTK) Stock Price, News & Analysis - Kalkine
Glucotrack expands IP to cover novel glucose monitor sensor architectures - Drug Delivery Business
Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM - Yahoo Finance
Glucotrack Issued Notice of Allowance by USPTO for Patent Application Covering Implantable CBGM Platform - citybiz
Glucotrack receives patent allowance for glucose monitoring system - Investing.com
GlucoTrack Issued US Patent Office Allowance for Blood Glucose Monitoring System - marketscreener.com
Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform - The Manila Times
Glucotrack Announces USPTO Notice Of Allowance For Patent Application Covering Its Implantable CBGM Platform - Menafn
Glucotrack patent wins USPTO notice as implantable glucose monitor advances - Stock Titan
GlucoTrack Inc. (GCTK) Holds Near Support Despite Modest DeclineLarge Cap Trends - DonanımHaber
GlucoTrack (GCTK) Stock Analysis Report | Financials & Insights - Benzinga
GlucoTrack Stock Declines 5% as Shares Test Key Support at $0.31Volume Breakout Ideas - dars.gov.et
GCTK Stock Is Soaring Today — What Is Fueling The Surge? - Stocktwits
GlucoTrack Inc (GCTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Price to sales forward of GlucoTrack, Inc. – NASDAQ:GCTK - TradingView
Price to book forward of GlucoTrack, Inc. – NASDAQ:GCTK - TradingView
GlucoTrack Inc (GCTK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GlucoTrack Inc (GCTK) Institutional Confidence - TradingKey
GlucoTrack Inc (GCTK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GlucoTrack Inc (GCTK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Glucotrack Inc (GCTK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.41%
0.18%
자본화:
|
볼륨(24시간):